Joshua A Kazam's Net Worth

$12.5 Million

Who is Joshua A Kazam?

Joshua A Kazam has an estimated net worth of $12.5 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., DENALI SCIENCES, INC., TS Innovation Acquisitions Corp., Tishman Speyer Innovation Corp. II, Flying Eagle Acquisition Corp., Platinum Eagle Acquisition Corp., Diamond Eagle Acquisition Corp. \ DE, Kronos Bio, Inc., Soaring Eagle Acquisition Corp., MANHATTAN PHARMACEUTICALS INC, Screaming Eagle Acquisition Corp., Kite Pharma, Inc., Nile Therapeutics, Inc., and Arno Therapeutics, Inc.

SEC CIK

Joshua A Kazam's CIK is 0001221355

Past Insider Trading and Trends

2019 was Joshua A Kazam's most active year for acquiring shares with 11 total transactions. Joshua A Kazam's most active month to acquire stocks was the month of May. 2017 was Joshua A Kazam's most active year for disposing of shares, totalling 6 transactions. Joshua A Kazam's most active month to dispose stocks was the month of September. 2018 saw Joshua A Kazam paying a total of $500,001.00 for 370,050 shares, this is the most they've acquired in one year. In 2017 Joshua A Kazam cashed out on 80,170 shares for a total of $12,285,889.90, their largest year based on trade value.